1 We investigated the efficacy and cost-effectiveness of outpat
2 We investigated the efficacy and safety of a low-Phe diet com
3 We investigated the efficacy and safety of a skin-patch vacci
4 We investigated the efficacy and safety of early hen's egg in
5 We investigated the efficacy and safety of emapalumab (a huma
6 We investigated the efficacy and safety of endoscopic resecti
7 In this prespecified analysis of FOURIER,
we investigated the efficacy and safety of evolocumab by diab
8 We investigated the efficacy and safety of evolocumab in pati
9 On the basis of this unmet need,
we investigated the efficacy and safety of fedratinib, a JAK2
10 We investigated the efficacy and safety of GSK2330672, a sele
11 In this phase II study,
we investigated the efficacy and safety of liposomal amikacin
12 We investigated the efficacy and safety of switching to a sin
13 We investigated the efficacy and safety of vosaroxin, a first
14 We investigated the efficacy and the safety of exercise provo
15 We investigated the efficacy and tolerability of fremanezumab
16 We investigated the efficacy and tolerability of MK-5172 with
17 In this study,
we investigated the efficacies of two experimental vaccines,
18 Therefore,
we investigated the efficacy of a novel 'modular' anesthesia
19 We investigated the efficacy of a recombinant mouse protein c
20 We investigated the efficacy of a reduced RUTF dose in commun
21 We investigated the efficacy of a self-led therapy app, 'List
22 We investigated the efficacy of a small molecule Gbetagamma i
23 nd the roles of CD4(+) T cells in the effects of adjuvants,
we investigated the efficacy of a T-dependent influenza virus
24 We investigated the efficacy of allele-specific silencing by
25 Here,
we investigated the efficacy of an engineered bacterium expre
26 In this study,
we investigated the efficacy of antibiotic therapies and the
27 Here
we investigated the efficacy of bacteriophage-therapy (phage)
28 Here,
we investigated the efficacy of calcipotriol, a topical TSLP
29 Here
we investigated the efficacy of CD11b or Ly-6C/Ly-6G-specific
30 Here,
we investigated the efficacy of chrysin, a plant flavonoid, w
31 In this multicentre, open-label, phase 3 study,
we investigated the efficacy of cilengitide in patients from
32 We investigated the efficacy of DAP in combination with AMP,
33 In the present study,
we investigated the efficacy of fenofibrate (Tricor), a pan-P
34 We investigated the efficacy of indole-3-carbinol (I3C), a di
35 We investigated the efficacy of locally administered heparin-
36 We investigated the efficacy of LTP treatments against bacter
37 Because this neurotoxicity involves ROS production,
we investigated the efficacy of mangafodipir, a molecule that
38 We investigated the efficacy of mesalamine in preventing recu
39 We investigated the efficacy of metabolomics for field-monito
40 We investigated the efficacy of oral single-dose azithromycin
41 We investigated the efficacy of resveratrol (RESV) for preven
42 We investigated the efficacy of sacituzumab govitecan, an ant
43 We investigated the efficacy of the addition of ezetimibe to
44 by which RAGE influences COPD in experimental COPD models,
we investigated the efficacy of the RAGE-specific antagonist
45 We investigated the efficacy of these NP adjuvants in inducin
46 Here,
we investigated the efficacy of using Maresin 1 (MaR1), an om
47 We investigated the efficacy,
safety and immunological respon
48 We investigated the efficacy,
safety, and tolerability of swi
49 We investigated the efficacy (
thrombotic events) and safety (
50 We investigated the efficacy,
tolerability, and pharmacokinet